[1] Kose S,Tosun G,Basok BI,et al.Prediction of ischemic placental diseases during the first trimester combined test period:a retrospective cohort of low-risk pregnancies in search of the link between parity and disease[J].J Matern Fetal Neonatal Med,2020,33(19):3272-3278. [2] 陈敦金,黄琳,陈兢思.缺血性胎盘起源母体远期疾病——综述与思考:妊娠期高血压疾病与母体远期疾病研究结果[J].中国实用妇科与产科杂志,2021,37(1):33-36. [3] 中国妇幼健康事业发展报告(2019)(一)[J].中国妇幼卫生杂志,2019,10(5):1-8. [4] 林建华,缪慧娴.加强妊娠合并心脏病多学科协作治疗模式管理,降低孕产妇死亡率[J].中国实用妇科与产科杂志,2019,35(11):1185-1188. [5] 王军,吴海波,单莉莉,等.心脏瓣膜置换术后患者妊娠临床管理[J].人民军医,2020,63(8): 814-819,822. [6] Regitz-Zagrosek V,Roos-Hesselink JW,Bauersachs J,et al.2018 ESC guidelines for the management of cardiovascular diseases during pregnancy[J].Eur Heart J, 2018,39(34): 3165-3241. [7] 谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:64-65. [8] 邹同安,季红薇,刘姣.妊娠期高血压患者血管内皮功能和氧自由基状况及其诊断意义[J].中国慢性病预防与控制,2020,28(6):456-458. |